Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Clinical Chemistry
|
November 13, 2023
Sensitive Blood-Based Detection of HIV-1 and Mycobacterium tuberculosis Peptides for Disease Diagnosis by Immuno-Affinity Liquid Chromatography-Tandem Mass Spectrometry: A Method Development and Proof-of-Concept Study
Lin Li, Christopher J Lyon, Sylvia M LaCourse, et al.
Diabetes, Obesity & Metabolism
|
April 15, 2024
Prediction of cardiovascular risk factors from retinal fundus photographs: Validation of a deep learning algorithm in a prospective non-interventional study in Kenya
Tom White, Viknesh Selvarajah, Fredrik Wolfhagen-Sand, et al.
The New England Journal of Medicine
|
June 15, 2019
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Elliott Vichinsky, Carolyn C Hoppe, Kenneth I Ataga, et al.
The New England Journal of Medicine
|
October 4, 2018
Phase 2b Controlled Trial of M72/AS01<sub>E</sub> Vaccine to Prevent Tuberculosis
Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba, et al.
The New England Journal of Medicine
|
October 30, 2019
Final Analysis of a Trial of M72/AS01<sub>E</sub> Vaccine to Prevent Tuberculosis
Dereck R Tait, Mark Hatherill, Olivier Van Der Meeren, et al.
The Lancet. Infectious Diseases
|
June 16, 2023
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial
Bernhards Ogutu, Adoke Yeka, Sylvia Kusemererwa, et al.
Journal of Clinical Pharmacology
|
September 30, 2024
Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 Study
Ramachandra Sangana, Bernhards Ogutu, Adoke Yeka, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Clinical Chemistry
|
November 13, 2023
Sensitive Blood-Based Detection of HIV-1 and Mycobacterium tuberculosis Peptides for Disease Diagnosis by Immuno-Affinity Liquid Chromatography-Tandem Mass Spectrometry: A Method Development and Proof-of-Concept Study
Lin Li, Christopher J Lyon, Sylvia M LaCourse, et al.
Diabetes, Obesity & Metabolism
|
April 15, 2024
Prediction of cardiovascular risk factors from retinal fundus photographs: Validation of a deep learning algorithm in a prospective non-interventional study in Kenya
Tom White, Viknesh Selvarajah, Fredrik Wolfhagen-Sand, et al.
The New England Journal of Medicine
|
June 15, 2019
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Elliott Vichinsky, Carolyn C Hoppe, Kenneth I Ataga, et al.
The New England Journal of Medicine
|
October 4, 2018
Phase 2b Controlled Trial of M72/AS01<sub>E</sub> Vaccine to Prevent Tuberculosis
Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba, et al.
The New England Journal of Medicine
|
October 30, 2019
Final Analysis of a Trial of M72/AS01<sub>E</sub> Vaccine to Prevent Tuberculosis
Dereck R Tait, Mark Hatherill, Olivier Van Der Meeren, et al.
The Lancet. Infectious Diseases
|
June 16, 2023
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial
Bernhards Ogutu, Adoke Yeka, Sylvia Kusemererwa, et al.
Journal of Clinical Pharmacology
|
September 30, 2024
Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 Study
Ramachandra Sangana, Bernhards Ogutu, Adoke Yeka, et al.
Page
of 4